AZN and SNY Related Headlines
Go Back- Dupilumab Could End of Being 'Blockbuster' Asthma Drug - Analyst (SNY) (REGN)
- Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM
- Amylin (AMLN) Bidding Intensifies; Sale Expected in July
